Anti-Trypanosoma cruzi antibodies in Latin American migrants in transit through the México- USA border

Laura Mayela Montes-Rincón, Lucio Galaviz-Silva, Zinnia Judith Molina-Garza, .

Keywords: Trypanosoma cruzi, enfermedad de Chagas, migrantes, estudios seroepidemiológicos, ensayo de inmunoadsorción enzimática, hemaglutinación

Abstract

Introduction: In recent years, American trypanosomiasis has become an emergent public health problem in countries receiving migrant populations such as México, USA, Canada or those in Europe.
Objective: To analyze the prevalence of anti-Trypanosoma cruzi antibodies in Latin American migrants on their way to USA and Canada by means of serological techniques.
Material and methods: ELISA and IHA were performed to detect anti-T. cruzi antibodies. Also, each participant filled out a socioeconomic questionnaire to determine the associated factors with seropositive cases, which could facilitate the transmission in the migrants’ country of origin.
Results: Total seroprevalence among the studied population was 20% (24/120). The highest prevalence was found in migrants from Guatemala with 37.5% (6/16), followed by Honduras (22.6%; 12/53), El Salvador (16%; 4/25), and México (8.7%, 3/23). From the total 120 surveyed migrants, 105 (87.5%) recognized the vector of Chagas’ disease, and 62 (59%) assured having been bitten by it. Highly significant statistical associations were found between infection and the construction materials for walls and the presence of pets (dogs) inside houses (p≤0.01), as well as with the building materials for backyards, inadequate basic services, and animal breeding inside corrals built around dwellings (p≤0.05).
Conclusion: Non-endemic countries receiving migrants from endemic areas should enhance or develop better health policies to prevent transfusion-transmitted Chagas or congenital parasite transmission.

Downloads

Download data is not yet available.
  • Laura Mayela Montes-Rincón Laboratorio de Patología Molecular y Experimental, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, Nuevo León, México
  • Lucio Galaviz-Silva Laboratorio de Patología Molecular y Experimental, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, Nuevo León, México
  • Zinnia Judith Molina-Garza Laboratorio de Patología Molecular y Experimental, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, Nuevo León, México

References

Montes-Rincón LM, Galaviz-Silva L, González-Bravo FE, Molina-Garza ZJ. Trypanosoma cruzi seroprevalence in pregnant women and screening by PCR and microhaematocrit in newborns from Guanajuato, México. Acta Trop. 2016;164:100-6. https://doi.org/10.1016/j.actatropica.2016.08.029

Carlier Y, Truyens C. Congenital Chagas disease as an ecological model of interactions between Trypanosoma cruzi parasites, pregnant women, placenta and fetuses. Acta Trop.2015;151:103-15. https://doi.org/10.1016/j.actatropica.2015.06.013

Rassi A Jr, Dias JC, Marin-Neto JA, Rassi A. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas’ disease. Heart. 2009;95:524-34.

https://doi.org/10.1136/hrt.2008.159624

Reisenman CE, Lawrence G, Guerenstein PG, Gregory T, Dotson E, Hildebrand JG. Infection of kissing bugs with Trypanosoma cruzi, Tucson Arizona, USA. Emerging Infect Dis. 2010;16:400-5. https://doi.org/10.3201/eid1603.090648

World Health Organization (WHO). Chagas Disease: Control and Elimination 2010. Fecha de consulta: 10 de diciembre del 2015. Disponible en: http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_17-en.pdf

Requena-Méndez A, Aldasoro E, de Lazzari E, Sicuri E, Brown M, Moore DA, et al. Prevalence of Chagas disease in Latin-American migrants living in Europe: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2015;9:e0003540. https://doi.org/10.1371/journal.pntd.0003540

Barona-Vilar C, Giménez-Martí MJ, Fraile T, González-Steinbauer C, Parada C, Gil-Brusola A, et al. Prevalence of Trypanosoma cruzi infection in pregnant Latin American women and congenital transmission rate in a non-endemic area: The experience of the Valencian Health Programme (Spain). Epidemiol Infect. 2012;140:1896-903. https://doi.org/10.1017/S0950268811002482

Pinazo MJ, Gascón J. The importance of the multidisciplinary approach to deal with the new epidemiological scenario of Chagas disease (global health). Acta Trop. 2015;151:16-20.

https://doi.org/10.1016/j.actatropica.2015.06.013

Gascón J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop. 2010;115:22-7. https://doi.org/10.1016/j.actatropica.2009.07.019

Lucas RM, Barba MC. Prevalence of American tripanosomiasis in pregnant women from a health area of Valencia, Spain. 2005-2007. Rev Esp Salud Pública. 2009;83:543-55.

Enríquez GF, Bua J, Orozco MM, Wirth S, Schijman AG, Gürtler RE, et al. High levels of Trypanosoma cruzi DNA determined by qPCR and infectiousness to Triatoma infestans support dogs and cats are major sources of parasites for domestic transmission. Infec Genet Evol. 2014;25:36-43. https://doi.org/10.1016/j.meegid.2014.04.002

Kjos SA, Marcet PL, Yabsley MJ, Kitron U, Snowden KF, Logan KS, et al. Identification of bloodmeal sources and Trypanosoma cruzi infection in triatomine bugs (Hemiptera: Reduviidae) from residential settings in Texas, the United States. J Med Entomol. 2013;50:1126-39. https://doi.org/10.1603/ME12242

Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009;49:52-54. https://doi.org/10.1086/605091

Instituto Nacional de Estadística (INE). Población migrante en España hasta el primer semestre de 2015. Fecha de consulta: 14 de diciembre de 2015. Disponible en: http:// www.ine.es/prensa/np948.pdf

Guerri-Guttenberg RA, Grana DR, Ambrosio G, Milei J. Chagas cardiomyopathy: Europe is not spared! Eur Heart J. 2008;29:2587-91. https://doi.org/10.1093/eurheartj/ehn424

Norma Oficial Mexicana, 2012. NOM-017-SSA2-2012:Para la vigilancia epidemiológica. Fecha de consulta: 2 de enero de 2014. Disponible en: http://dof.gob.mx/nota_detalle.php?codigo=5288225&fecha=19/02/2013

Rosecrans K, Cruz-Martin G, King A, Dumonteil E. Opportunities for improved Chagas disease vector control based on knowledge, attitudes and practices of communities in the Yucatán Peninsula, México. PLoS Negl Trop Dis. 2014;8:e2763. https://doi.org/10.1371/journal.pntd.0002763

Galavíz-Silva L, Molina-Garza DP, González-Santos MA, Mercado-Hernández R, González-Galavíz JR, Rosales-Encina JL, et al. Update on seroprevalence of anti-Trypanosoma cruzi antibodies among blood donors in northeast México. Am J Trop Med Hyg. 2009;81:404-6

World Health Organization. Control of Chagas disease. Fecha de consulta: 14 de marzo de 2015. Disponible en: http://apps.who.int/iris/bitstream/10665/42443/1/WHO_

TRS_905.pdf

Centers for Disease Control and Prevention (CDC). Parasites - American Trypanosomiasis (also known as Chagas Disease): Diagnosis. Fecha de consulta: 2 de diciembre del 2015. Disponible en: http://www.cdc.gov/parasites/chagas/health_professionals/dx.html.

Organización Panamericana de la Salud (OPS). Estimación cuantitativa de la enfermedad de Chagas 2006. Fecha de consulta: 2 de enero del 2016. Disponible en: http://www.bvsops.org.uy/pdf/chagas19.pdf

Coura JR, Viñas PA. Chagas disease: A new worldwide challenge. Nature. 2010;465:S6-S7. https://doi.org/10.1038/nature09221

Vakis R, Rigolini J, Lucchetti L. Los olvidados, pobreza crónica en América Latina y el Caribe. Washington, D.C.: Banco Internacional de Reconstrucción y Fomento/Banco Mundial; 2015. Fecha de consulta: 2 de enero de 2016. Disponible en: https://openknowledge.worldbank.org/bitstream/handle/10986/21552/Left%20Behind%20Overview%20SPANISH.pdf?sequence=5

Tanowitz HB, Weiss LM, Montgomery SP. Chagas disease has now gone global. PLoS Negl Trop Dis. 2011;5:e1136. https://doi.org/10.1371/journal.pntd.0001136

Navarro M, Navaza B, Guionnet A, López-Vélez R. Chagas disease in Spain: Need for further public health measures. PLoS Negl Trop Dis. 2012;6:e1962. https://doi.org/10.1371/journal.pntd.0001962

World Health Organization. New global effort to eliminate Chagas disease. Partners set out strategy against the ‘kissing bug’ disease. Fecha de consulta: 15 de diciembre de 2015. Disponible en: http://www.who.int/mediacentre/news/releases/2007/pr36/en/

Fearon MA, Scalia V, Huang M, Dines I, Ndao M, Lagacé-Wiens P. A case of vertical transmission of Chagas disease contracted via blood transfusion in Canada. Can J Infect Dis Med Microbiol. 2013;24:32-4.

Guzmán-Bracho C. Epidemiology of Chagas disease in México: An update. Trends Parasitol. 2001;17:372-6. https://doi.org/10.1016/S1471-4922(01)01952-3

Pew Hispanic Center (PHC). Pew report: Foreign born population at mid-decade. Fecha de consulta: 12 de diciembre de 2015. Disponible en: http://www.pewhispanic.org/2006/10/17/a-statistical-portrait-of-the-foreign-bornpopulation-at-mid-decade/.

Ortí-Lucas RM, Parada-Barba MC, de la Rubia-Ortí JE, Carrillo-Ruiz A, Beso-Delgado M, Boone AL. Impact of Chagas disease in Bolivian immigrants living in Europe and the risk of stigmatization. J Parasitol Res. 2014;2014:1-7. https://doi.org/10.1155/2014/514794

Zaniello BA, Kessler DA, Vine KM, Grima KM, Weisenberg SA. Seroprevalence of Chagas infection in the donor population. PLoS Negl Trop Dis. 2012;6:e1771. https://doi.org/10.1371/journal.pntd.0001771

Steele LS, MacPherson DW, Kim J, Keystone JS, Gushulak BD. The sero-prevalence of antibodies to Trypanosoma cruzi in Latin American refugees and immigrants to Canada. J Immigr Minor Health. 2007;9:43-7. https://doi.org/10.1007/s10903-006-9014-x

Klotza SA, Dorn PL, Klotz JH, Pinnas JL, Weirauch C, Kurtz JR, et al. Feeding behavior of triatomines from the southwestern United States: An update on potential risk for transmission of Chagas disease. Acta Trop. 2009;111:114-8. https://doi.org/10.1016/j.actatropica.2009.03.003

How to Cite
1.
Montes-Rincón LM, Galaviz-Silva L, Molina-Garza ZJ. Anti-Trypanosoma cruzi antibodies in Latin American migrants in transit through the México- USA border. biomedica [Internet]. 2018 Mar. 15 [cited 2024 May 16];38(1):54-60. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/3526

Some similar items:

Published
2018-03-15
Section
Original articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code